Questionnaire Study to Investigate the Preferences of Children, Parents, and Healthcare Professionals for Different Formulations of Oral Medicinal Products
-
Published:2024-04-08
Issue:4
Volume:16
Page:515
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Wargenau Manfred1, Baase Felicitas2, Eckardt Kristin1ORCID, Spitzhorn Lucas-Sebastian1, Reidemeister Sibylle3, Klingmann Ingrid4, Klingmann Viviane2ORCID
Affiliation:
1. M.A.R.C.O. GmbH & Co. KG, Institute for Clinical Research and Statistics, Schirmerstrasse 71, 40211 Duesseldorf, Germany 2. Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Duesseldorf, 40225 Duesseldorf, Germany 3. Novartis Pharma AG, Global Drug Development/Technical Research & Development, Novartis Campus, 4056 Basel, Switzerland 4. Pharmaplex bv, Avenue Saint-Hubert 51, 1970 Wezembeek-Oppem, Belgium
Abstract
Since the acceptability of a medicine can significantly impact therapeutic outcomes, this study aimed to determine and compare the preferences of children, parents, and healthcare professionals for the most commonly used pediatric oral medicine formulations (syrup, mini-tablets, oblong tablets, round tablets) addressing all pediatric age groups, 0–<18 years (y). This survey study employed sex-, age-, and participant group-adapted questionnaires for eight cohorts of participants, i.e., children 6–<12 y, adolescents 12–<18 y, parents of children in four age groups (0–<2 y, 2–<6 y, 6–<12 y, and 12–<18 y), nurses, and pediatricians. Descriptive statistics were used for data analysis. In the age groups 0–<2 y and 2–<6 y, mini-tablets were preferred over syrup by all participants. In the age group 6–12 y, solid dosage forms were also preferred over syrup by all participants. In the age group 12–<18 y, healthcare professionals preferred solid dosage forms over syrup. Parents preferred higher amounts of mini-tablets and syrup compared to round and oblong tablets, while adolescents’ preferences did not differentiate between these formulations. Based on the study results and in contrast to current practice, it is suggested to consider solid dosage forms for future age-appropriate medicinal products already for younger age groups.
Funder
Department of General Pediatrics, Neonatology, and Pediatric Cardiology of the University Hospital Düsseldorf, Germany
Reference35 articles.
1. Lopalco, A., and Denora, N. (2020). Paediatric Formulation: Design and Development. Int. J. Mol. Sci., 21. 2. Paediatric specific dosage forms: Patient and formulation considerations;Khan;Int. J. Pharm.,2022 3. Vallet, T., Elhamdaoui, O., Berraho, A., Cherkaoui, L.O., Kriouile, Y., Mahraoui, C., Mouane, N., Pense-Lheritier, A.M., Ruiz, F., and Bensouda, Y. (2020). Medicines Acceptability in Hospitalized Children: An Ongoing Need for Age-Appropriate Formulations. Pharmaceutics, 12. 4. European Medicines Agency, Committee for Medicinal Products for Human Use, and Paediatric Committee (2024, January 08). Guideline on Pharmaceutical Development of Medicines for Paediatric Use. Available online: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf. 5. Alessandrini, E., Brako, F., Scarpa, M., Lupo, M., Bonifazi, D., Pignataro, V., Cavallo, M., Cullufe, O., Enache, C., and Nafria, B. (2021). Children’s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure). Pharmaceutics, 13.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|